TrialHeadache2020

Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster Headache.

David Kudrow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.